AARS2-Related Ovarioleukodystrophy: A Patient Guide

AARS2-related ovarioleukodystrophy is a rare genetic condition that primarily affects two seemingly different systems: the white matter of the brain and the function of the ovaries. At its core, the condition is a mitochondrial disorder, meaning it stems from a “glitch” in the parts of the cells responsible for producing energy. When these cellular powerhouses cannot function correctly due to mutations in the AARS2 gene, the high-energy tissues in the brain and reproductive system begin to struggle, leading to the two hallmarks of the disease—leukoencephalopathy (white matter damage) and premature ovarian insufficiency (POI), a condition distinct from predictable natural menopause ^[1][2]. Importantly, the broader AARS2 spectrum can also include heart muscle disease (cardiomyopathy), particularly in early-onset cases, so cardiac evaluation is often recommended.

For most people, the condition unfolds gradually, often beginning in early adulthood with subtle changes that can be difficult to pin down. These may include shifts in mood or behavior, challenges with complex thinking and planning, or physical changes such as clumsiness or stiffness when walking. In people with ovaries, these neurological symptoms are frequently accompanied or preceded by early menopause or the absence of a menstrual cycle ^[1][3]. Because these symptoms overlap with many more common conditions, receiving a definitive genetic diagnosis is a significant milestone that helps bring clarity to a long and often confusing medical journey ^[4].

While the condition is progressive, it is also highly variable; the experience of one person may look very different from another, with some individuals remaining stable for many years. Managing the disease currently focuses on supportive care, which means assembling a dedicated team of specialists—including neurologists, endocrinologists, cardiologists, and therapists—to address symptoms and protect long-term health, particularly bone and heart health. Moving forward with this diagnosis involves a shift toward proactive monitoring and symptom management, aimed at maintaining independence and quality of life while staying connected to the latest developments in rare disease research ^[5][6].

What to Do After Diagnosis

The immediate goals after receiving this diagnosis are to:

1. Confirm the variant classification with a genetics professional.
2. Establish a neurologic and functional baseline with your care team.
3. Assess ovarian and endocrine needs.
4. Review whether baseline cardiac evaluation (EKG/echocardiogram) is appropriate.
5. Identify a coordinating clinician to manage your comprehensive care.